Abstract:Background: Although surgery plays a key role in the treatment of the primary retroperitoneal sarcoma (RPS), there remain few reports on the primary multifocal RPS. Aims: This study aimed to identify the prognostic factors for the primary multifocal RPS in an effort to optimize the clinical management of this malignancy. Methods: A retrospective analysis was conducted on a cohort of 319 primary RPS patients who underwent radical resection from 2009 to 2021, with post-operative recurrence as the primary endpoint of this study. COX regression was performed to identify the risk factors for post-operative recurrence, and a comparison was made to baseline and prognostic differences between multivisceral resection (MVR) and non-MVR groups with multifocal disease. Results: There were 31 (9.7%) patients with multifocal disease, the mean tumor burden placed on them was 24.1 ± 11.9 cm, and nearly half of the patients (48.4%) had MVR. Dedifferentiated liposarcoma, well-differentiated liposarcoma, and leiomyosarcoma accounted for 38.7%, 32.3%, and 16.1%, respectively. The 5-year recurrence-free survival rate reached 31.2% (95% CI, 11.2–51.2%) in the multifocal group and 51.8% (95% CI, 44.2–59.4%) in the unifocal group (P = 0.010). Age (heart rate [HR] = 0.916; P = 0.039) and complete resection (HR = 1.861; P = 0.043) were identified as the independent risk factors for the post-operative recurrence of multifocal primary RPS. Conclusions: Regarding primary multifocal RPS, the overall treatment strategy can be adopted for the treatment of the primary RPS, and MVR remains effective in boosting the chance of disease control for a selected group of patients. Relevance for Patients: This study is relevant to patients as it highlights the importance of receiving appropriate treatment for the primary RPS, especially for those with multifocal disease. The treatment options should be evaluated carefully to ensure that the patients receive the most effective treatment for their specific type and stage of RPS. The potential risk factors for post-operative recurrence should be well understood to minimize those risks. Ultimately, this study underscores the importance of ongoing research to optimize the clinical management of RPS and improve outcomes for patients.

Treatment algorithm and surgical outcome for primary and recurrent retroperitoneal sarcomas: A long-term single-center experience of 242 cases

Survival and prognostic factors of primary retroperitoneal sarcomas after surgery: a single-center experience

Sarcomatoid carcinoma of the renal pelvis: Experience of multiple cases over a ten-year period.

Survival Outcomes of Surgery for Retroperitoneal Sarcomas: A Systematic Review and Meta-Analysis

Short‐ and Long‐term Surgical Outcomes of Pancreatic Resection for Retroperitoneal Sarcoma: A Long‐term Single‐center Experience of 90 Cases

Surgical Treatment of Recurrent Retroperitoneal Soft Tissue Sarcoma: Report of 25 Cases

Aggressive Surgical Approach with Vascular Resection and Reconstruction for Retroperitoneal Sarcomas: a Systematic Review

Progress in Retroperitoneal Sarcoma Management: Surgical and Radiotherapy Approaches

Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group

Unplanned Reoperation after Resection of Retroperitoneal Sarcoma: Experience Based on a High-Volume Sarcoma Center

Longitudinal and time-to-event modeling for prognostic implications of radical surgery in retroperitoneal sarcoma

Patients with First Recurrent Retroperitoneal Sarcoma That Can Be Macroscopically Completely Resected Can Achieve Comparable Outcomes with That of Primary Patients after En Bloc Resection of Tumor and Adjacent Organs

Risk factors for recurrence and survival in patients with primary retroperitoneal tumors.

Can Primary Retroperitoneal Sarcoma Benefit from Aggressive Resection when It is Smaller Than a Baseball? ——A Propensity Score-Matched Analysis

Comprehensive treatment strategy for improving surgical resection rate of retroperitoneal sarcomas: a histology-specific approach narrative review

Surgical Management Of Retroperitoneal Sarcoma And Opportunities For Global Collaboration

Management of Retroperitoneal Liposarcoma: A Case Report and Review of the Literature.

Prognostic Factors of Retroperitoneal Soft Tissue Sarcomas: Analysis of 132 Cases

Multivisceral Resection of Primary Multifocal Retroperitoneal Sarcomas: a Retrospective Study from a High-Volume Sarcoma Center.

Treatment strategy and long-term outcomes of primary intracranial rhabdomyosarcoma: a single-institution experience and systematic review

Does Aggressive Surgery Mean Worse Quality of Life and Functional Capacity in Retroperitoneal Sarcoma Patients?—A Retrospective Study of 161 Patients from China